Conference Coverage
Conference Coverage
Certain DMTs in MS may attenuate COVID-19 vaccines
Adjust timing if feasible, neurologist says, but focus on getting shots in arms.
Conference Coverage
Natalizumab postinfusion reactions rare; is monitoring necessary?
New findings “highlight a potential opportunity to improve and streamline the infusion and post-infusion monitoring process.”
Conference Coverage
NfL levels linked to worse disability in real-world MS
New findings shed light on how best to apply serum filament light chain levels to individual patients.
Conference Coverage
Vitamin D deficiency linked to early cognitive impairment in MS
This association might represent a marker of future disability, supporting the need for prompt supplementation.
Conference Coverage
Opioid use common for pain in multiple sclerosis
“Better pain management treatment options, including nonpharmacological options, are needed for people with MS and pain.”
Conference Coverage
NfL blood biomarker captures suboptimal treatment response in MS
“Our data in this well-characterized large real-world cohort supports the value of serum NfL levels for treatment monitoring in MS clinical...
Conference Coverage
Newer DMTs are more effective than injectable DMTs in pediatric MS
A retrospective study suggests that the safety and tolerability of newer disease-modifying therapies are the same in children as in adults.
Conference Coverage
Neutrophil granulocyte markers may distinguish between demyelinating diseases
Evaluating CSF for neutrophil granulocyte markers may help distinguish between MS, neuromyelitis optica spectrum disorders, and anti–myelin...
Conference Coverage
Bacteria may be associated with risk of MS relapse
A study of patients with pediatric-onset MS suggests that methanogenesis pathways may play a role in the risk of relapse.
Conference Coverage
COVID-19 risks are no higher in patients with multiple sclerosis
MS does not appear to be associated with higher risks of severe COVID-19 outcomes compared with the general population.